Skip to main content
Top
Published in: Journal of Clinical Immunology 2/2012

01-04-2012

Expanding the Clinical and Genetic Spectrum of Human CD40L Deficiency: The Occurrence of Paracoccidioidomycosis and Other Unusual Infections in Brazilian Patients

Authors: Otavio Cabral-Marques, Lena-Friederike Schimke, Paulo Vítor Soeiro Pereira, Angela Falcai, João Bosco de Oliveira, Mary J. Hackett, Paolo Ruggero Errante, Cristina Worm Weber, Janaíra Fernandes Ferreira, Gisele Kuntze, Nelson Augusto Rosário-Filho, Hans D. Ochs, Troy R. Torgerson, Beatriz Tavares Costa Carvalho, Antonio Condino-Neto

Published in: Journal of Clinical Immunology | Issue 2/2012

Login to get access

Abstract

CD40 ligand (CD40L) deficiency or X-linked hyper-IgM syndrome (X-HIGM) is a well-described primary immunodeficiency in which Pneumocystis jiroveci pneumonia is a common clinical feature. We have identified an unusual high incidence of fungal infections and other not yet described infections in a cohort of 11 X-HIGM patients from nine unrelated Brazilian families. Among these, we describe the first case of paracoccidioidomycosis (PCM) in X-HIGM. The molecular genetic analysis of CD40L was performed by gene sequencing and evaluation of CD40L protein expression. Nine of these 11 patients (82%) had fungal infections. These included fungal species common to CD40L deficiency (P. jiroveci and Candida albicans) as well as Paracoccidioides brasiliensis. One patient presented with PCM at age 11 years and is now doing well at 18 years of age. Additionally, one patient presented with a simultaneous infection with Klebsiella and Acinetobacter, and one with condyloma caused by human papilloma virus. Molecular analysis revealed four previously described CD40L mutations, two novel missense mutations (c.433 T > G and c.476 G > C) resulting in the absence of CD40L protein expression by activated CD4+ cells and one novel insertion (c.484_485insAA) within the TNFH domain leading to a frame shift and premature stop codon. These observations demonstrated that the susceptibility to fungal infections in X-HIGM extends beyond those typically associated with X-HIGM (P. jiroveci and C. albicans) and that these patients need to be monitored for those pathogens.
Literature
1.
go back to reference Liu L, Okada S, Kong XF, Kreins AY, Cypowyj S, Abhyankar A, Toubiana J, Itan Y, Audry M, Nitschke P, Masson C, Toth B, Flatot J, Migaud M, Chrabieh M, Kochetkov T, Bolze A, Borghesi A, Toulon A, Hiller J, Eyerich S, Eyerich K, Gulacsy V, Chernyshova L, Chernyshov V, Bondarenko A, Maria Cortes Grimaldo R, Blancas-Galicia L, Madrigal Beas IM, Roesler J, Magdorf K, Engelhard D, Thumerelle C, Burgel PR, Hoernes M, Drexel B, Seger R, Kusuma T, Jansson AF, Sawalle-Belohradsky J, Belohradsky B, Jouanguy E, Bustamante J, Bue M, Karin N, Wildbaum G, Bodemer C, Lortholary O, Fischer A, Blanche S, Al-Muhsen S, Reichenbach J, Kobayashi M, Rosales FE, Lozano CT, Kilic SS, Oleastro M, Etzioni A, Traidl-Hoffmann C, Renner ED, Abel L, Picard C, Marodi L, Boisson-Dupuis S, Puel A, Casanova JL. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med. 2011;208:1635–48.PubMedCrossRef Liu L, Okada S, Kong XF, Kreins AY, Cypowyj S, Abhyankar A, Toubiana J, Itan Y, Audry M, Nitschke P, Masson C, Toth B, Flatot J, Migaud M, Chrabieh M, Kochetkov T, Bolze A, Borghesi A, Toulon A, Hiller J, Eyerich S, Eyerich K, Gulacsy V, Chernyshova L, Chernyshov V, Bondarenko A, Maria Cortes Grimaldo R, Blancas-Galicia L, Madrigal Beas IM, Roesler J, Magdorf K, Engelhard D, Thumerelle C, Burgel PR, Hoernes M, Drexel B, Seger R, Kusuma T, Jansson AF, Sawalle-Belohradsky J, Belohradsky B, Jouanguy E, Bustamante J, Bue M, Karin N, Wildbaum G, Bodemer C, Lortholary O, Fischer A, Blanche S, Al-Muhsen S, Reichenbach J, Kobayashi M, Rosales FE, Lozano CT, Kilic SS, Oleastro M, Etzioni A, Traidl-Hoffmann C, Renner ED, Abel L, Picard C, Marodi L, Boisson-Dupuis S, Puel A, Casanova JL. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med. 2011;208:1635–48.PubMedCrossRef
2.
go back to reference Puel A, Cypowyj S, Bustamante J, Wright JF, Liu L, Lim HK, Migaud M, Israel L, Chrabieh M, Audry M, Gumbleton M, Toulon A, Bodemer C, El-Baghdadi J, Whitters M, Paradis T, Brooks J, Collins M, Wolfman NM, Al-Muhsen S, Galicchio M, Abel L, Picard C, Casanova JL. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science. 2011;332:65–8.PubMedCrossRef Puel A, Cypowyj S, Bustamante J, Wright JF, Liu L, Lim HK, Migaud M, Israel L, Chrabieh M, Audry M, Gumbleton M, Toulon A, Bodemer C, El-Baghdadi J, Whitters M, Paradis T, Brooks J, Collins M, Wolfman NM, Al-Muhsen S, Galicchio M, Abel L, Picard C, Casanova JL. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science. 2011;332:65–8.PubMedCrossRef
3.
go back to reference Ryan KR, Hong M, Arkwright PD, Gennery AR, Costigan C, Dominguez M, Denning D, McConnell V, Cant AJ, Abinun M, Spickett GP, Lilic D. Impaired dendritic cell maturation and cytokine production in patients with chronic mucocutaneous candidiasis with or without APECED. Clin Exp Immunol. 2008;154:406–14.PubMedCrossRef Ryan KR, Hong M, Arkwright PD, Gennery AR, Costigan C, Dominguez M, Denning D, McConnell V, Cant AJ, Abinun M, Spickett GP, Lilic D. Impaired dendritic cell maturation and cytokine production in patients with chronic mucocutaneous candidiasis with or without APECED. Clin Exp Immunol. 2008;154:406–14.PubMedCrossRef
4.
go back to reference Schimke K, Chubb SA, Davis WA, Davis TM. Helicobacter pylori cytotoxin-associated gene-A antibodies do not predict complications or death in type 2 diabetes: the Fremantle Diabetes Study. Atherosclerosis. 2010;212:321–6.PubMedCrossRef Schimke K, Chubb SA, Davis WA, Davis TM. Helicobacter pylori cytotoxin-associated gene-A antibodies do not predict complications or death in type 2 diabetes: the Fremantle Diabetes Study. Atherosclerosis. 2010;212:321–6.PubMedCrossRef
5.
go back to reference Fuleihan R, Ramesh N, Geha RS. Role of CD40–CD40-ligand interaction in Ig-isotype switching. Curr Opin Immunol. 1993;5:963–7.PubMedCrossRef Fuleihan R, Ramesh N, Geha RS. Role of CD40–CD40-ligand interaction in Ig-isotype switching. Curr Opin Immunol. 1993;5:963–7.PubMedCrossRef
6.
go back to reference Allen RC, Armitage RJ, Conley ME, Rosenblatt H, Jenkins NA, Copeland NG, Bedell MA, Edelhoff S, Disteche CM, Simoneaux DK, et al. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science. 1993;259:990–3.PubMedCrossRef Allen RC, Armitage RJ, Conley ME, Rosenblatt H, Jenkins NA, Copeland NG, Bedell MA, Edelhoff S, Disteche CM, Simoneaux DK, et al. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science. 1993;259:990–3.PubMedCrossRef
7.
go back to reference Aruffo A, Farrington M, Hollenbaugh D, Li X, Milatovich A, Nonoyama S, Bajorath J, Grosmaire LS, Stenkamp R, Neubauer M, et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell. 1993;72:291–300.PubMedCrossRef Aruffo A, Farrington M, Hollenbaugh D, Li X, Milatovich A, Nonoyama S, Bajorath J, Grosmaire LS, Stenkamp R, Neubauer M, et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell. 1993;72:291–300.PubMedCrossRef
8.
go back to reference DiSanto JP, Bonnefoy JY, Gauchat JF, Fischer A, de Saint Basile G. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature. 1993;361:541–3.PubMedCrossRef DiSanto JP, Bonnefoy JY, Gauchat JF, Fischer A, de Saint Basile G. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature. 1993;361:541–3.PubMedCrossRef
9.
go back to reference Fuleihan R, Ramesh N, Loh R, Jabara H, Rosen RS, Chatila T, Fu SM, Stamenkovic I, Geha RS. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc Natl Acad Sci U S A. 1993;90:2170–3.PubMedCrossRef Fuleihan R, Ramesh N, Loh R, Jabara H, Rosen RS, Chatila T, Fu SM, Stamenkovic I, Geha RS. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc Natl Acad Sci U S A. 1993;90:2170–3.PubMedCrossRef
10.
go back to reference Hostoffer RW, Berger M, Clark HT, Schreiber JR. Disseminated Histoplasma capsulatum in a patient with hyper IgM immunodeficiency. Pediatrics. 1994;94:234–6.PubMed Hostoffer RW, Berger M, Clark HT, Schreiber JR. Disseminated Histoplasma capsulatum in a patient with hyper IgM immunodeficiency. Pediatrics. 1994;94:234–6.PubMed
11.
go back to reference Levy J, Espanol-Boren T, Thomas C, Fischer A, Tovo P, Bordigoni P, Resnick I, Fasth A, Baer M, Gomez L, Sanders EA, Tabone MD, Plantaz D, Etzioni A, Monafo V, Abinun M, Hammarstrom L, Abrahamsen T, Jones A, Finn A, Klemola T, DeVries E, Sanal O, Peitsch MC, Notarangelo LD. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr. 1997;131:47–54.PubMedCrossRef Levy J, Espanol-Boren T, Thomas C, Fischer A, Tovo P, Bordigoni P, Resnick I, Fasth A, Baer M, Gomez L, Sanders EA, Tabone MD, Plantaz D, Etzioni A, Monafo V, Abinun M, Hammarstrom L, Abrahamsen T, Jones A, Finn A, Klemola T, DeVries E, Sanal O, Peitsch MC, Notarangelo LD. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr. 1997;131:47–54.PubMedCrossRef
12.
go back to reference Nonoyama S, Shimadzu M, Toru H, Seyama K, Nunoi H, Neubauer M, Yata J, Och HD. Mutations of the CD40 ligand gene in 13 Japanese patients with X-linked hyper-IgM syndrome. Hum Genet. 1997;99:624–7.PubMedCrossRef Nonoyama S, Shimadzu M, Toru H, Seyama K, Nunoi H, Neubauer M, Yata J, Och HD. Mutations of the CD40 ligand gene in 13 Japanese patients with X-linked hyper-IgM syndrome. Hum Genet. 1997;99:624–7.PubMedCrossRef
13.
go back to reference Winkelstein JA, Marino MC, Ochs H, Fuleihan R, Scholl PR, Geha R, Stiehm ER, Conley ME. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore). 2003;82:373–84.CrossRef Winkelstein JA, Marino MC, Ochs H, Fuleihan R, Scholl PR, Geha R, Stiehm ER, Conley ME. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore). 2003;82:373–84.CrossRef
15.
go back to reference Al-Muhsen S, Casanova JL. The genetic heterogeneity of mendelian susceptibility to mycobacterial diseases. J Allergy Clin Immunol. 2008;122:1043–51. quiz 1052–1043.PubMedCrossRef Al-Muhsen S, Casanova JL. The genetic heterogeneity of mendelian susceptibility to mycobacterial diseases. J Allergy Clin Immunol. 2008;122:1043–51. quiz 1052–1043.PubMedCrossRef
16.
go back to reference Notarangelo LD, Fischer A, Geha RS, Casanova JL, Chapel H, Conley ME, Cunningham-Rundles C, Etzioni A, Hammartrom L, Nonoyama S, Ochs HD, Puck J, Roifman C, Seger R, Wedgwood J. Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol. 2009;124:1161–78.PubMedCrossRef Notarangelo LD, Fischer A, Geha RS, Casanova JL, Chapel H, Conley ME, Cunningham-Rundles C, Etzioni A, Hammartrom L, Nonoyama S, Ochs HD, Puck J, Roifman C, Seger R, Wedgwood J. Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol. 2009;124:1161–78.PubMedCrossRef
17.
go back to reference Stavnezer J. Complex regulation and function of activation-induced cytidine deaminase. Trends Immunol. 2011;32:194–201.PubMedCrossRef Stavnezer J. Complex regulation and function of activation-induced cytidine deaminase. Trends Immunol. 2011;32:194–201.PubMedCrossRef
18.
go back to reference Seyama K, Nonoyama S, Gangsaas I, Hollenbaugh D, Pabst HF, Aruffo A, Ochs HD. Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome. Blood. 1998;92:2421–34.PubMed Seyama K, Nonoyama S, Gangsaas I, Hollenbaugh D, Pabst HF, Aruffo A, Ochs HD. Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome. Blood. 1998;92:2421–34.PubMed
19.
go back to reference Schwarz JM, Rodelsperger C, Schuelke M, Seelow D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods. 2010;7:575–6.PubMedCrossRef Schwarz JM, Rodelsperger C, Schuelke M, Seelow D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods. 2010;7:575–6.PubMedCrossRef
20.
go back to reference Kraakman EM, Bontrop RE, Groenestein R, Jonker M, Haaijman JJ, t Hart BA. Characterization of the natural immune response of rhesus monkey CD4 + ve T cells to the bacterial antigen streptolysin O (SLO). J Med Primatol. 1995;24:306–12.PubMedCrossRef Kraakman EM, Bontrop RE, Groenestein R, Jonker M, Haaijman JJ, t Hart BA. Characterization of the natural immune response of rhesus monkey CD4 + ve T cells to the bacterial antigen streptolysin O (SLO). J Med Primatol. 1995;24:306–12.PubMedCrossRef
21.
go back to reference Jo EK, Kim HS, Lee MY, Iseki M, Lee JH, Song CH, Park JK, Hwang TJ, Kook H. X-linked hyper-IgM syndrome associated with Cryptosporidium parvum and Cryptococcus neoformans infections: the first case with molecular diagnosis in Korea. J Korean Med Sci. 2002;17:116–20.PubMed Jo EK, Kim HS, Lee MY, Iseki M, Lee JH, Song CH, Park JK, Hwang TJ, Kook H. X-linked hyper-IgM syndrome associated with Cryptosporidium parvum and Cryptococcus neoformans infections: the first case with molecular diagnosis in Korea. J Korean Med Sci. 2002;17:116–20.PubMed
22.
go back to reference Nucci M, Queiroz-Telles F, Tobon AM, Restrepo A, Colombo AL. Epidemiology of opportunistic fungal infections in Latin America. Clin Infect Dis. 2010;51:561–70.PubMedCrossRef Nucci M, Queiroz-Telles F, Tobon AM, Restrepo A, Colombo AL. Epidemiology of opportunistic fungal infections in Latin America. Clin Infect Dis. 2010;51:561–70.PubMedCrossRef
23.
go back to reference Benard G, Duarte AJ. Paracoccidioidomycosis: a model for evaluation of the effects of human immunodeficiency virus infection on the natural history of endemic tropical diseases. Clin Infect Dis. 2000;31:1032–9.PubMedCrossRef Benard G, Duarte AJ. Paracoccidioidomycosis: a model for evaluation of the effects of human immunodeficiency virus infection on the natural history of endemic tropical diseases. Clin Infect Dis. 2000;31:1032–9.PubMedCrossRef
24.
go back to reference Moraes-Vasconcelos D, Grumach AS, Yamaguti A, Andrade ME, Fieschi C, de Beaucoudrey L, Casanova JL, Duarte AJ. Paracoccidioides brasiliensis disseminated disease in a patient with inherited deficiency in the beta1 subunit of the interleukin (IL)-12/IL-23 receptor. Clin Infect Dis. 2005;41:e31–37.PubMedCrossRef Moraes-Vasconcelos D, Grumach AS, Yamaguti A, Andrade ME, Fieschi C, de Beaucoudrey L, Casanova JL, Duarte AJ. Paracoccidioides brasiliensis disseminated disease in a patient with inherited deficiency in the beta1 subunit of the interleukin (IL)-12/IL-23 receptor. Clin Infect Dis. 2005;41:e31–37.PubMedCrossRef
25.
go back to reference Barrozo LV, Mendes RP, Marques SA, Benard G, Silva ME, Bagagli E. Climate and acute/subacute paracoccidioidomycosis in a hyper-endemic area in Brazil. Int J Epidemiol. 2009;38:1642–9.PubMedCrossRef Barrozo LV, Mendes RP, Marques SA, Benard G, Silva ME, Bagagli E. Climate and acute/subacute paracoccidioidomycosis in a hyper-endemic area in Brazil. Int J Epidemiol. 2009;38:1642–9.PubMedCrossRef
26.
go back to reference Shikanai-Yasuda MA, Telles Filho Fde Q, Mendes RP, Colombo AL, Moretti ML. Guidelines in paracoccidioidomycosis. Rev Soc Bras Med Trop. 2006;39:297–310.PubMedCrossRef Shikanai-Yasuda MA, Telles Filho Fde Q, Mendes RP, Colombo AL, Moretti ML. Guidelines in paracoccidioidomycosis. Rev Soc Bras Med Trop. 2006;39:297–310.PubMedCrossRef
27.
go back to reference Bellissimo-Rodrigues F, Machado AA, Martinez R. Paracoccidioidomycosis epidemiological features of a 1,000-cases series from a hyperendemic area on the southeast of Brazil. Am J Trop Med Hyg. 2011;85:546–50.PubMedCrossRef Bellissimo-Rodrigues F, Machado AA, Martinez R. Paracoccidioidomycosis epidemiological features of a 1,000-cases series from a hyperendemic area on the southeast of Brazil. Am J Trop Med Hyg. 2011;85:546–50.PubMedCrossRef
28.
go back to reference Rolon PA. Paracoccidioidomycosis: an epidemic in the Republic of Paraguay, the center of South America. Mycopathologia. 1976;59:67–80.PubMedCrossRef Rolon PA. Paracoccidioidomycosis: an epidemic in the Republic of Paraguay, the center of South America. Mycopathologia. 1976;59:67–80.PubMedCrossRef
29.
go back to reference McEwen JG, Bedoya V, Patino MM, Salazar ME, Restrepo A. Experimental murine paracoccidioidomycosis induced by the inhalation of conidia. J Med Vet Mycol. 1987;25:165–75.PubMedCrossRef McEwen JG, Bedoya V, Patino MM, Salazar ME, Restrepo A. Experimental murine paracoccidioidomycosis induced by the inhalation of conidia. J Med Vet Mycol. 1987;25:165–75.PubMedCrossRef
30.
go back to reference Morejon KM, Machado AA, Martinez R. Paracoccidioidomycosis in patients infected with and not infected with human immunodeficiency virus: a case–control study. Am J Trop Med Hyg. 2009;80:359–66.PubMed Morejon KM, Machado AA, Martinez R. Paracoccidioidomycosis in patients infected with and not infected with human immunodeficiency virus: a case–control study. Am J Trop Med Hyg. 2009;80:359–66.PubMed
31.
go back to reference Bethlem EP, Capone D, Maranhao B, Carvalho CR, Wanke B. Paracoccidioidomycosis. Curr Opin Pulm Med. 1999;5:319–25.PubMedCrossRef Bethlem EP, Capone D, Maranhao B, Carvalho CR, Wanke B. Paracoccidioidomycosis. Curr Opin Pulm Med. 1999;5:319–25.PubMedCrossRef
33.
go back to reference Brummer E, Castaneda E, Restrepo A. Paracoccidioidomycosis: an update. Clin Microbiol Rev. 1993;6:89–117.PubMed Brummer E, Castaneda E, Restrepo A. Paracoccidioidomycosis: an update. Clin Microbiol Rev. 1993;6:89–117.PubMed
34.
go back to reference Fonseca ER, Pardal PP, Severo LC. Paracoccidioidomycosis in children in Belem, Para. Rev Soc Bras Med Trop. 1999;32:31–3.PubMedCrossRef Fonseca ER, Pardal PP, Severo LC. Paracoccidioidomycosis in children in Belem, Para. Rev Soc Bras Med Trop. 1999;32:31–3.PubMedCrossRef
35.
go back to reference Pereira PM, Akel PB, Lima LL, Kimura EN, Jalkh AP. Multifocal paracoccidioidomycosis: a diagnostic challenge due to late cutaneous manifestation. An Bras Dermatol. 2011;86:149–52.PubMedCrossRef Pereira PM, Akel PB, Lima LL, Kimura EN, Jalkh AP. Multifocal paracoccidioidomycosis: a diagnostic challenge due to late cutaneous manifestation. An Bras Dermatol. 2011;86:149–52.PubMedCrossRef
36.
go back to reference Brazao-Silva MT, Andrade MF, Franco T, Ribeiro RI, Silva Wdos S, Faria G, Faria PR, Cardoso SV, Loyola AM. Paracoccidioidomycosis: a series of 66 patients with oral lesions from an endemic area. Mycoses. 2011;54:e189–195.PubMedCrossRef Brazao-Silva MT, Andrade MF, Franco T, Ribeiro RI, Silva Wdos S, Faria G, Faria PR, Cardoso SV, Loyola AM. Paracoccidioidomycosis: a series of 66 patients with oral lesions from an endemic area. Mycoses. 2011;54:e189–195.PubMedCrossRef
38.
go back to reference Gasparetto EL, Liu CB, de Carvalho Neto A, Rogacheski E. Central nervous system paracoccidioidomycosis: imaging findings in 17 cases. J Comput Assist Tomogr. 2003;27:12–7.PubMedCrossRef Gasparetto EL, Liu CB, de Carvalho Neto A, Rogacheski E. Central nervous system paracoccidioidomycosis: imaging findings in 17 cases. J Comput Assist Tomogr. 2003;27:12–7.PubMedCrossRef
39.
go back to reference Goldani LZ. Gastrointestinal paracoccidioidomycosis: an overview. J Clin Gastroenterol. 2011;45:87–91.PubMedCrossRef Goldani LZ. Gastrointestinal paracoccidioidomycosis: an overview. J Clin Gastroenterol. 2011;45:87–91.PubMedCrossRef
40.
go back to reference Odashiro AN, Odashiro PR, Fernandes PI, Leite LV, Odashiro M, Maloney S, Fernandes BF, Di Cesare S, Burnier Jr MN. Eyelid and conjunctival paracoccidioidomycosis simulating carcinoma. Int Ophthalmol. 2011;31:63–7.PubMedCrossRef Odashiro AN, Odashiro PR, Fernandes PI, Leite LV, Odashiro M, Maloney S, Fernandes BF, Di Cesare S, Burnier Jr MN. Eyelid and conjunctival paracoccidioidomycosis simulating carcinoma. Int Ophthalmol. 2011;31:63–7.PubMedCrossRef
41.
go back to reference Costa DL, Dias-Melicio LA, Acorci MJ, Bordon AP, Tavian EG, Peracoli MT, Soares AM. Effect of interleukin-10 on the Paracoccidioides brasiliensis killing by gamma-interferon activated human neutrophils. Microbiol Immunol. 2007;51:73–80.PubMed Costa DL, Dias-Melicio LA, Acorci MJ, Bordon AP, Tavian EG, Peracoli MT, Soares AM. Effect of interleukin-10 on the Paracoccidioides brasiliensis killing by gamma-interferon activated human neutrophils. Microbiol Immunol. 2007;51:73–80.PubMed
42.
go back to reference Cabral Marques, O., C. Arslanian, R. Nalio Ramos, M. Morato, Paulo Vitor Soeiro, Sonia Jancar MD, Janaíra Fernandes Ferreira, Cristina Worm Weber, Gisele Kuntze, Nelson Augusto Rosario, Beatriz Tavares Costa Carvalho, Patricia Cruz Bergami-Santos, Mary J. Hackett, Hans D. Ochs, Troy R. Torgerson, Jose Alexandre Marzagão Barbuto, and Antonio Condino-Neto. Dendritic cells from X-linked Hyper IgM patients demonstrate defective responses to the fungal pathogens Candida albicans and Paracoccidioides brasiliensis. J Allergy Clin Immunol. 2011 (in press). Cabral Marques, O., C. Arslanian, R. Nalio Ramos, M. Morato, Paulo Vitor Soeiro, Sonia Jancar MD, Janaíra Fernandes Ferreira, Cristina Worm Weber, Gisele Kuntze, Nelson Augusto Rosario, Beatriz Tavares Costa Carvalho, Patricia Cruz Bergami-Santos, Mary J. Hackett, Hans D. Ochs, Troy R. Torgerson, Jose Alexandre Marzagão Barbuto, and Antonio Condino-Neto. Dendritic cells from X-linked Hyper IgM patients demonstrate defective responses to the fungal pathogens Candida albicans and Paracoccidioides brasiliensis. J Allergy Clin Immunol. 2011 (in press).
43.
44.
go back to reference Rezaei N, Hedayat M, Aghamohammadi A, Nichols KE. Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies. J Allergy Clin Immunol. 2011;127:1329–41. e1322; quiz 1342–1323.PubMedCrossRef Rezaei N, Hedayat M, Aghamohammadi A, Nichols KE. Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies. J Allergy Clin Immunol. 2011;127:1329–41. e1322; quiz 1342–1323.PubMedCrossRef
45.
go back to reference Banatvala N, Davies J, Kanariou M, Strobel S, Levinsky R, Morgan G. Hypogammaglobulinaemia associated with normal or increased IgM (the hyper IgM syndrome): a case series review. Arch Dis Child. 1994;71:150–2.PubMedCrossRef Banatvala N, Davies J, Kanariou M, Strobel S, Levinsky R, Morgan G. Hypogammaglobulinaemia associated with normal or increased IgM (the hyper IgM syndrome): a case series review. Arch Dis Child. 1994;71:150–2.PubMedCrossRef
46.
go back to reference Jeena P, Thompson E, Nchabeleng M, Sturm A. Emergence of multi-drug-resistant Acinetobacter anitratus species in neonatal and paediatric intensive care units in a developing country: concern about antimicrobial policies. Ann Trop Paediatr. 2001;21:245–51.PubMedCrossRef Jeena P, Thompson E, Nchabeleng M, Sturm A. Emergence of multi-drug-resistant Acinetobacter anitratus species in neonatal and paediatric intensive care units in a developing country: concern about antimicrobial policies. Ann Trop Paediatr. 2001;21:245–51.PubMedCrossRef
47.
go back to reference Omwandho CO, Gruessner SE, Tinneberg HR. Early pregnancy loss and neonatal deaths associated with Klebsiella pneumonia infection: a mini review of possible occupational health risk. Arch Gynecol Obstet. 2006;273:258–60.PubMedCrossRef Omwandho CO, Gruessner SE, Tinneberg HR. Early pregnancy loss and neonatal deaths associated with Klebsiella pneumonia infection: a mini review of possible occupational health risk. Arch Gynecol Obstet. 2006;273:258–60.PubMedCrossRef
48.
go back to reference Soler-Palacin P, Margareto C, Llobet P, Asensio O, Hernandez M, Caragol I, Espanol T. Chronic granulomatous disease in pediatric patients: 25 years of experience. Allergol Immunopathol (Madr). 2007;35:83–9.CrossRef Soler-Palacin P, Margareto C, Llobet P, Asensio O, Hernandez M, Caragol I, Espanol T. Chronic granulomatous disease in pediatric patients: 25 years of experience. Allergol Immunopathol (Madr). 2007;35:83–9.CrossRef
49.
go back to reference Jacobs ZD, Guajardo JR, Anderson KM. XLA-associated neutropenia treatment: a case report and review of the literature. J Pediatr Hematol Oncol. 2008;30:631–4.PubMedCrossRef Jacobs ZD, Guajardo JR, Anderson KM. XLA-associated neutropenia treatment: a case report and review of the literature. J Pediatr Hematol Oncol. 2008;30:631–4.PubMedCrossRef
50.
go back to reference Jain N, Euler GL, Shefer A, Lu P, Yankey D, Markowitz L. Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007. Prev Med. 2009;48:426–31.PubMedCrossRef Jain N, Euler GL, Shefer A, Lu P, Yankey D, Markowitz L. Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007. Prev Med. 2009;48:426–31.PubMedCrossRef
51.
go back to reference Hernandez PA, Gorlin RJ, Lukens JN, Taniuchi S, Bohinjec J, Francois F, Klotman ME, Diaz GA. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat Genet. 2003;34:70–4.PubMedCrossRef Hernandez PA, Gorlin RJ, Lukens JN, Taniuchi S, Bohinjec J, Francois F, Klotman ME, Diaz GA. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat Genet. 2003;34:70–4.PubMedCrossRef
52.
go back to reference Guerra-Maranhao MC, Costa-Carvalho BT, Nudelman V, Barros-Nunes P, Carneiro-Sampaio MM, Arslanian C, et al. Response to polysaccharide antigens in patients with ataxia-telangiectasia. J Pediatr (Rio J). 2006;82(2):132–6. Guerra-Maranhao MC, Costa-Carvalho BT, Nudelman V, Barros-Nunes P, Carneiro-Sampaio MM, Arslanian C, et al. Response to polysaccharide antigens in patients with ataxia-telangiectasia. J Pediatr (Rio J). 2006;82(2):132–6.
Metadata
Title
Expanding the Clinical and Genetic Spectrum of Human CD40L Deficiency: The Occurrence of Paracoccidioidomycosis and Other Unusual Infections in Brazilian Patients
Authors
Otavio Cabral-Marques
Lena-Friederike Schimke
Paulo Vítor Soeiro Pereira
Angela Falcai
João Bosco de Oliveira
Mary J. Hackett
Paolo Ruggero Errante
Cristina Worm Weber
Janaíra Fernandes Ferreira
Gisele Kuntze
Nelson Augusto Rosário-Filho
Hans D. Ochs
Troy R. Torgerson
Beatriz Tavares Costa Carvalho
Antonio Condino-Neto
Publication date
01-04-2012
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 2/2012
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-011-9623-6

Other articles of this Issue 2/2012

Journal of Clinical Immunology 2/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.